about
Personalized medicine in diabetes: the role of 'omics' and biomarkersPharmacogenomics in diabetes mellitus: insights into drug action and drug discoveryDrug interventions for the treatment of obesity in children and adolescentsUnderstanding and overcoming metformin gastrointestinal intolerance.Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks.Delphinidin Reduces Glucose Uptake in Mice Jejunal Tissue and Human Intestinal Cells Lines through FFA1/GPR40.18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users.The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults.Metformin: clinical use in type 2 diabetes.A Structural Basis for Biguanide Activity.A phase Ib study of everolimus combined with metformin for patients with advanced cancer.The Role of Gut-brain Axis in Regulating Glucose Metabolism After Acute Pancreatitis.Roles of the gut in the metabolic syndrome: an overview.Combatting type 2 diabetes by turning up the heat.Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.Could metformin be used in patients with diabetes and advanced chronic kidney disease?Metformin: New Preparations and Nonglycemic Benefits.Nutrient sensing pathways as therapeutic targets for healthy ageing.Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.Vascular complications in diabetes: old messages, new thoughts.Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut Bacteria.The mechanisms of action of metformin.Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients.Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.Metformin-associated lactic acidosis: Moving towards a new paradigm?Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis.Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes and metabolic disease.Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.Health benefits of late-onset metformin treatment every other week in mice.Pharmacological management of type 2 diabetes: what's new in 2017?60 years of metformin use: a glance at the past and a look to the future.Metformin: historical overview.
P2860
Q26775259-080DB576-D80D-436E-B205-F81F9E64B866Q28274686-28049316-F225-413A-A25A-252588F13DCAQ28279770-08C6D3F6-6724-4577-A4E3-614AB1DC1FB0Q30240030-1B441558-D000-4221-9644-3702E93A2ED4Q30400204-B54F18FC-C2B2-4ED2-963F-0225357E342FQ33624480-A6EBC397-8E6E-4529-83D9-CEEFC4E66E37Q33626631-1D2AE6EA-2974-4DB5-8215-70FC59DC87F1Q33658321-AD33483D-2031-4B3A-9403-7740F70C25C6Q37059366-62F2BCB3-0911-4DCD-BF21-B9FBEDFF49C7Q37222650-D6D69637-0530-4E3C-B739-46F31991DDDEQ37456235-162F1D2E-D9CC-4F8C-B8A3-1E53B868D1E5Q37622726-7B8B3670-179E-431E-931C-30379765FEBEQ37673171-73F7B3EC-5FB5-4F01-B952-112B96307BAEQ37715482-7CF7C9F9-8493-4FAE-8CD0-A011DAAEB863Q38645273-32214DA3-1E1D-438B-904B-6F8B1BABB6BBQ38647178-504FDB1E-B4C5-4E64-B86A-2AC28D526EB0Q38670844-639B2F6B-1EA0-4D32-B606-35A71BBD37EAQ38774623-192D69D3-2CEF-4CFD-835B-A88D46ACDC8BQ38780926-B946C0CC-1984-4A18-ADD7-50789DDA6DD1Q38945649-55F1FF0D-8C20-46D2-8F6C-93FC601B39E6Q38948037-569B892E-0400-487D-8F63-838663FDED4EQ38968961-5B4908B9-7074-4976-8E47-E59FDFE92E45Q39100209-0849D304-EF7D-4609-AA7E-813C2382453DQ39172757-A611810F-10E5-44AF-A18D-D4D7CBAFAD43Q39247550-34609811-4B3B-458C-85B3-7F072B92840FQ39446720-D12E5A42-4C19-4B52-8D03-A0BB22A8C0A4Q40468370-F9C68D28-9EF5-42F6-8701-44140853D25EQ41206250-14018732-703E-4E14-9C01-7108F97D3CECQ41353984-4BB5278F-3D94-4EE0-9733-F39433B2742AQ41999356-0C0D4278-7E81-436A-B1E8-9EBB5783F74FQ43246916-312DCBCB-C42F-445C-9C38-FB8905C48AAEQ45047162-5E749707-756A-4F57-B13F-C44552934FEFQ46295009-196610CF-170C-4D96-89EE-6FCD30660A08Q47117670-10328132-976B-4976-984C-5883FD3EC07EQ47127733-6672EC90-E064-4B9D-80D3-EB8E89125D5DQ47202033-F41D4D36-886A-4BBC-936D-9F01605AC804Q47304462-C3061F9D-7869-4BAB-AE3C-E0796CEC73EDQ47696671-865E1CB9-8B2D-4D8E-BCDD-AEC43B3C05D1Q48004902-7A630CBF-0EA8-48DD-AAF3-C073C9ECAFF6Q48004913-10BFC45D-EB59-487D-8393-C78EAB2C7449
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Metformin and the gastrointestinal tract
@ast
Metformin and the gastrointestinal tract
@en
Metformin and the gastrointestinal tract
@nl
type
label
Metformin and the gastrointestinal tract
@ast
Metformin and the gastrointestinal tract
@en
Metformin and the gastrointestinal tract
@nl
prefLabel
Metformin and the gastrointestinal tract
@ast
Metformin and the gastrointestinal tract
@en
Metformin and the gastrointestinal tract
@nl
P2860
P921
P3181
P1433
P1476
Metformin and the gastrointestinal tract
@en
P2093
Laura J McCreight
P2860
P2888
P304
P3181
P356
10.1007/S00125-015-3844-9
P407
P577
2016-01-16T00:00:00Z
P5875
P6179
1019933356